53,376 Shares in BlackRock Health Sciences Term Trust (NYSE:BMEZ) Purchased by Brooklyn FI LLC

Brooklyn FI LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 53,376 shares of the company’s stock, valued at approximately $826,000.

Several other institutional investors have also added to or reduced their stakes in BMEZ. Brown Brothers Harriman & Co. purchased a new position in shares of BlackRock Health Sciences Term Trust in the third quarter valued at $32,000. K2 Principal Fund L.P. bought a new position in BlackRock Health Sciences Term Trust in the 3rd quarter worth about $158,000. Jane Street Group LLC purchased a new position in BlackRock Health Sciences Term Trust during the 3rd quarter valued at about $357,000. Corient Private Wealth LLC increased its position in shares of BlackRock Health Sciences Term Trust by 24.9% during the fourth quarter. Corient Private Wealth LLC now owns 26,225 shares of the company’s stock valued at $378,000 after buying an additional 5,224 shares during the period. Finally, GWN Securities Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth about $404,000.

BlackRock Health Sciences Term Trust Stock Up 0.9 %

Shares of NYSE:BMEZ opened at $15.21 on Thursday. The company has a 50 day moving average of $15.80 and a 200 day moving average of $15.63. BlackRock Health Sciences Term Trust has a 12 month low of $14.27 and a 12 month high of $16.75.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be given a dividend of $0.1763 per share. The ex-dividend date is Friday, March 14th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 13.91%.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.